The dual-acting GLP-1/GIP Tirzepatide oral drop provides powerful support in a convenient, once-weekly, needle-free dose. Designed to help curb appetite, promote weight loss, and enhance metabolic health, it fits seamlessly into your routine—simply swish in your mouth. No injections, no refrigeration, and no daily dosing—just an effortless way to support your health goals.
Science-Backed Weight Support
GLP-1/GIP receptor agonists, when studied in injectable form, have been associated with significant reductions in body weight when combined with healthy lifestyle changes. This compounded oral formulation is designed to leverage similar pathways that may help support appetite regulation, satiety, and overall weight-related goals under the guidance of a licensed healthcare provider.
Advanced Appetite & Craving Control
By mimicking the body’s natural incretin hormones (GLP-1 and GIP), this compound may help slow digestion, reduce hunger signals, and minimize cravings. Many patients report feeling fuller longer, making it easier to stick to nutrition goals without feeling deprived.
Improved Blood Sugar Regulation
GLP-1/GIP therapies have been shown to help stabilize blood glucose by increasing insulin response after meals and reducing excess glucagon. This benefit may support individuals with prediabetes, insulin resistance, or type 2 diabetes as part of a comprehensive care plan.
Cardiometabolic Support
In addition to weight loss, patients may experience improvements in cholesterol levels, blood pressure, all of which contribute to better cardiovascular and metabolic health.
Once-Weekly Convenience with EllievaTec™
This compounded formula utilizes EllievaTec™, a proprietary absorption technology developed over more than a decade and designed to support delivery through the oral cavity. While individual results may vary, this approach is intended to offer a needle-free, once-weekly option without the need for refrigeration or daily dosing, making it a convenient addition to a wellness routine when prescribed by a licensed provider.
This product is prescribed by a licensed healthcare provider based on the individual needs. These statements and the product have not been evaluated or approved by the Food and Drug Administration (FDA). This product is not intended to diagnose, treat, cure, or prevent any disease. Compounded medications are not FDA-approved, and their safety and efficacy have not been independently verified by the FDA. This information is provided for educational purposes only and should not be considered medical advice.
Tirzepatide Oral Drops Tirzepatide Oral Drops are a compounded, once-weekly, needle-free formulation designed to support weight management, appetite control, and metabolic health. As a dual GLP-1/GIP receptor agonist, this therapy is formulated for sublingual use under the supervision of a licensed healthcare provider. While tirzepatide has been extensively studied in injectable form, this compounded oral version offers a convenient, non-injectable alternative for eligible patients.
Tirzepatide Oral Drops may be appropriate for individuals seeking to support healthy weight loss, manage appetite, or improve metabolic markers under the care of a licensed healthcare provider. They may also be considered in cases of insulin resistance, prediabetes, or other weight-related health concerns. This formulation is particularly suitable for those who prefer to avoid injections and want the convenience of a needle-free, oral alternative.
Use should always be medically supervised, especially for individuals with pre-existing health conditions or those taking other medications. These compounded drops are not FDA-approved and are available only by prescription through a 503A compounding pharmacy.
Tirzepatide therapy may not be appropriate for everyone and should never be used without medical supervision. This treatment may not be suitable for individuals who:
Always consult with a licensed healthcare provider to determine whether tirzepatide is safe and appropriate for you.
The most commonly reported side effects include:
These effects are generally mild and often improve as your body adjusts to treatment. Always inform your healthcare provider about any side effects you experience. In rare cases, more serious reactions may occur. Seek immediate medical attention if you develop symptoms of an allergic reaction (such as rash, swelling, or difficulty breathing) or if you experience severe or persistent abdominal pain.
Yes, but only under medical supervision. Tirzepatide therapy may sometimes be combined with other medications or peptide treatments, such as NAD+. A licensed healthcare provider will carefully review your medical history, current treatments, and health goals to determine whether this combination is safe and appropriate for you.
FrontCare partners with Pharmacies that may compound Semaglutide and Tirzepatode formulations with Vitamin B12 (cyanocobalamin). This essential nutrient plays a critical role in energy metabolism and overall health, enhancing the therapeutic benefits of treatment and making these compounded options distinct from standard commercially available alternatives.
Vitamin B12 belongs to a group of molecules called cobalamins, which include hydroxocobalamin, adenosylcobalamin, and cyanocobalamin. Each contains cobalt at its core; when cobalt interacts with water, its salts form a pink-colored solution, known as a metal aquo complex.
All compounded medications are prepared in compliance with Section 503A of the Federal Food, Drug, and Cosmetic Act, ensuring patient-specific formulations that meet high standards of safety and care.
Yes, a licensed provider will review your medical history before prescribing; however, we strongly recommend also informing your primary care physician of any new treatments, including compounded peptides. This helps ensure safe, coordinated, and comprehensive care tailored to your overall health.
The Platform gives you full access to the frontcare partner ecosystem: